查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1530910

注射給藥市場 - 2024-2034 年全球產業分析、規模、佔有率、成長、趨勢和預測

Injectable Drug Delivery Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 263 Pages | 商品交期: 2-10個工作天內

價格

注射給藥市場 - 報告範圍

TMR 關於全球注射給藥市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2024 年至 2034 年預測期內市場指標的寶貴見解。 2034年期間的市場，考慮2024年為基準年，2034年為預測年。該報告也提供了2024年至2034年全球注射給藥市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解注射給藥市場。

市場概況
2023年市場價值 6895 億美元
2034 年市場價值 1.9 美元
複合年成長率 9.8%

該報告深入研究了全球注射給藥市場的競爭格局。全球注射給藥市場的主要參與者已被確定，並且每個參與者都已根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球注射給藥市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2020-2034 年全球市場分析與預測

第 5 章：關鍵見解

  • PEST分析
  • 產品發布和批准
  • 關鍵地區/國家的監管環境
  • FDA 藥品核准流程
  • 關鍵產業事件（收購、合作與協作）

第 6 章：全球市場分析與預測：依產品類型

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年按產品類型分類的市場價值預測
    • 裝置
      • 傳統注射裝置
      • 自注射裝置
      • 其他
    • 配方
      • 常規給藥製劑
      • 新型藥物傳輸製劑
      • 長效注射劑配方
  • 按產品類型分類的市場吸引力

第 7 章：全球市場分析與預測：依治療應用分類

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年治療應用市場價值預測
    • 自體免疫疾病
    • 荷爾蒙疾病
    • 孤兒病
    • 癌症
    • 心血管疾病
    • 傳染病
    • 其他
  • 治療應用的市場吸引力

第 8 章：全球市場分析與預測：按使用模式

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年按使用模式分類的市場價值預測
    • 治療護理
    • 免疫接種
    • 其他
  • 按使用模式分類的市場吸引力

第 9 章：全球市場分析與預測：按最終用戶

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年最終用戶市場價值預測
    • 醫院和診所
    • 門診手術中心
    • 家庭護理設置
    • 其他
  • 最終用戶的市場吸引力

第 10 章：全球市場分析與預測：按地區

  • 主要發現
  • 各地區市場價值預測
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 按國家/地區分類的市場吸引力

第 11 章：北美市場分析與預測

  • 美國
  • 加拿大

第 12 章：歐洲市場分析與預測

  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 歐洲其他地區

第 13 章：亞太市場分析與預測

  • 中國
  • 印度
  • 日本
  • 澳洲和紐西蘭
  • 亞太地區其他地區

第 14 章：拉丁美洲市場分析與預測

  • 巴西
  • 墨西哥
  • 拉丁美洲其他地區

第 15 章：中東和非洲市場分析與預測

  • 海灣合作理事會
  • 南非
  • 中東和非洲其他地區

第16章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 公司市佔率分析（2021 年）
  • 市場足跡分析
    • By Product Type
  • 競爭商業策略
  • 公司簡介
    • 市場參與者 - 競爭矩陣（依公司層級和規模）
    • 市佔率分析：依公司分類（2023）
    • 公司簡介
Product Code: TMRGL1336

Injectable Drug Delivery Market - Scope of Report

TMR's report on the global injectable drug delivery market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global injectable drug delivery market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global injectable drug delivery market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the injectable drug delivery market.

Market Snapshot
Market Value in 2023US$ 689.5 Bn
Market Value in 2034US$ 1.9 Trn
CAGR9.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global injectable drug delivery market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global injectable drug delivery market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global injectable drug delivery market.

The report delves into the competitive landscape of the global injectable drug delivery market. Key players operating in the global injectable drug delivery market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global injectable drug delivery market profiled in this report.

Key Questions Answered in Global injectable drug delivery Market Report:

  • What is the sales/revenue generated by injectable drug delivery across all regions during the forecast period?
  • What are the opportunities in the global injectable drug delivery market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Injectable Drug Delivery Market - Research Objectives and Research Approach

The comprehensive report on the global injectable drug delivery market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global injectable drug delivery market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global injectable drug delivery market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Injectable Drug Delivery Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Injectable Drug Delivery Market Analysis and Forecasts, 2020-2034
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. PEST Analysis
  • 5.2. Product Launches and Approvals
  • 5.3. Regulatory Landscape for Injectable Drug Delivery in Key Regions / Countries
  • 5.4. FDA Drug Approval Process
  • 5.5. Key Industry Events (Acquisition, Partnerships, And Collaborations)

6. Global Injectable Drug Delivery Market Analysis and Forecasts, By Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product Type, 2020-2034
    • 6.3.1. Devices
      • 6.3.1.1. Conventional Injection Devices
      • 6.3.1.2. Self Injection Devices
      • 6.3.1.3. Others
    • 6.3.2. Formulations
      • 6.3.2.1. Conventional Drug Delivery Formulations
      • 6.3.2.2. Novel Drug Delivery Formulations
      • 6.3.2.3. Long Lasting Injection Formulations
  • 6.4. Market Attractiveness By Product Type

7. Global Injectable Drug Delivery Market Analysis and Forecasts, By Therapeutic Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Therapeutic Application, 2020-2034
    • 7.3.1. Autoimmune Disease
    • 7.3.2. Hormone Disease
    • 7.3.3. Orphan Disease
    • 7.3.4. Cancer
    • 7.3.5. Cardiovascular Disease
    • 7.3.6. Infectious Disease
    • 7.3.7. Others
  • 7.4. Market Attractiveness By Therapeutic Application

8. Global Injectable Drug Delivery Market Analysis and Forecasts, By Usage Pattern

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Usage Pattern, 2020-2034
    • 8.3.1. Curative Care
    • 8.3.2. Immunization
    • 8.3.3. Others
  • 8.4. Market Attractiveness By Usage Pattern

9. Global Injectable Drug Delivery Market Analysis and Forecasts, By End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By End-user, 2020-2034
    • 9.3.1. Hospitals and Clinics
    • 9.3.2. Ambulatory Surgical Centers
    • 9.3.3. Home Care Settings
    • 9.3.4. Others
  • 9.4. Market Attractiveness By End-user

10. Global Injectable Drug Delivery Market Analysis and Forecasts, By Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast By Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Injectable Drug Delivery Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product Type, 2020-2034
    • 11.2.1. Devices
      • 11.2.1.1. Conventional Injection Devices
      • 11.2.1.2. Self Injection Devices
      • 11.2.1.3. Others
    • 11.2.2. Formulations
      • 11.2.2.1. Conventional Drug Delivery Formulations
      • 11.2.2.2. Novel Drug Delivery Formulations
      • 11.2.2.3. Long Lasting Injection Formulations
  • 11.3. Market Value Forecast By Therapeutic Application, 2020-2034
    • 11.3.1. Autoimmune Disease
    • 11.3.2. Hormone Disease
    • 11.3.3. Orphan Disease
    • 11.3.4. Cancer
    • 11.3.5. Cardiovascular Disease
    • 11.3.6. Infectious Disease
    • 11.3.7. Others
  • 11.4. Market Value Forecast By Usage Pattern, 2020-2034
    • 11.4.1. Curative Care
    • 11.4.2. Immunization
    • 11.4.3. Others
  • 11.5. Market Value Forecast By End-user, 2020-2034
    • 11.5.1. Hospitals and Clinics
    • 11.5.2. Ambulatory Surgical Centers
    • 11.5.3. Home Care Settings
    • 11.5.4. Others
  • 11.6. Market Value Forecast By Country, 2020-2034
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product Type
    • 11.7.2. By Therapeutic Application
    • 11.7.3. By Usage Pattern
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Injectable Drug Delivery Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product Type, 2020-2034
    • 12.2.1. Devices
      • 12.2.1.1. Conventional Injection Devices
      • 12.2.1.2. Self Injection Devices
      • 12.2.1.3. Others
    • 12.2.2. Formulations
      • 12.2.2.1. Conventional Drug Delivery Formulations
      • 12.2.2.2. Novel Drug Delivery Formulations
      • 12.2.2.3. Long Lasting Injection Formulations
  • 12.3. Market Value Forecast By Therapeutic Application, 2020-2034
    • 12.3.1. Autoimmune Disease
    • 12.3.2. Hormone Disease
    • 12.3.3. Orphan Disease
    • 12.3.4. Cancer
    • 12.3.5. Cardiovascular Disease
    • 12.3.6. Infectious Disease
    • 12.3.7. Others
  • 12.4. Market Value Forecast By Usage Pattern, 2020-2034
    • 12.4.1. Curative Care
    • 12.4.2. Immunization
    • 12.4.3. Others
  • 12.5. Market Value Forecast By End-user, 2020-2034
    • 12.5.1. Hospitals and Clinics
    • 12.5.2. Ambulatory Surgical Centers
    • 12.5.3. Home Care Settings
    • 12.5.4. Others
  • 12.6. Market Value Forecast By Country, 2020-2034
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product Type
    • 12.7.2. By Therapeutic Application
    • 12.7.3. By Usage Pattern
    • 12.7.4. By End-user
    • 12.7.5. By Country

13. Asia Pacific Injectable Drug Delivery Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product Type, 2020-2034
    • 13.2.1. Devices
      • 13.2.1.1. Conventional Injection Devices
      • 13.2.1.2. Self Injection Devices
      • 13.2.1.3. Others
    • 13.2.2. Formulations
      • 13.2.2.1. Conventional Drug Delivery Formulations
      • 13.2.2.2. Novel Drug Delivery Formulations
      • 13.2.2.3. Long Lasting Injection Formulations
  • 13.3. Market Value Forecast By Therapeutic Application, 2020-2034
    • 13.3.1. Autoimmune Disease
    • 13.3.2. Hormone Disease
    • 13.3.3. Orphan Disease
    • 13.3.4. Cancer
    • 13.3.5. Cardiovascular Disease
    • 13.3.6. Infectious Disease
    • 13.3.7. Others
  • 13.4. Market Value Forecast By Usage Pattern, 2020-2034
    • 13.4.1. Curative Care
    • 13.4.2. Immunization
    • 13.4.3. Others
  • 13.5. Market Value Forecast By End-user, 2020-2034
    • 13.5.1. Hospitals and Clinics
    • 13.5.2. Ambulatory Surgical Centers
    • 13.5.3. Home Care Settings
    • 13.5.4. Others
  • 13.6. Market Value Forecast By Country, 2020-2034
    • 13.6.1. China
    • 13.6.2. India
    • 13.6.3. Japan
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product Type
    • 13.7.2. By Therapeutic Application
    • 13.7.3. By Usage Pattern
    • 13.7.4. By End-user
    • 13.7.5. By Country

14. Latin America Injectable Drug Delivery Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product Type, 2020-2034
    • 14.2.1. Devices
      • 14.2.1.1. Conventional Injection Devices
      • 14.2.1.2. Self Injection Devices
      • 14.2.1.3. Others
    • 14.2.2. Formulations
      • 14.2.2.1. Conventional Drug Delivery Formulations
      • 14.2.2.2. Novel Drug Delivery Formulations
      • 14.2.2.3. Long Lasting Injection Formulations
  • 14.3. Market Value Forecast By Therapeutic Application, 2020-2034
    • 14.3.1. Autoimmune Disease
    • 14.3.2. Hormone Disease
    • 14.3.3. Orphan Disease
    • 14.3.4. Cancer
    • 14.3.5. Cardiovascular Disease
    • 14.3.6. Infectious Disease
    • 14.3.7. Others
  • 14.4. Market Value Forecast By Usage Pattern, 2020-2034
    • 14.4.1. Curative Care
    • 14.4.2. Immunization
    • 14.4.3. Others
  • 14.5. Market Value Forecast By End-user, 2020-2034
    • 14.5.1. Hospitals and Clinics
    • 14.5.2. Ambulatory Surgical Centers
    • 14.5.3. Home Care Settings
    • 14.5.4. Others
  • 14.6. Market Value Forecast By Country, 2020-2034
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product Type
    • 14.7.2. By Therapeutic Application
    • 14.7.3. By Usage Pattern
    • 14.7.4. By End-user
    • 14.7.5. By Country

15. Middle East & Africa Injectable Drug Delivery Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Product Type, 2020-2034
    • 15.2.1. Devices
      • 15.2.1.1. Conventional Injection Devices
      • 15.2.1.2. Self Injection Devices
      • 15.2.1.3. Others
    • 15.2.2. Formulations
      • 15.2.2.1. Conventional Drug Delivery Formulations
      • 15.2.2.2. Novel Drug Delivery Formulations
      • 15.2.2.3. Long Lasting Injection Formulations
  • 15.3. Market Value Forecast By Therapeutic Application, 2020-2034
    • 15.3.1. Autoimmune Disease
    • 15.3.2. Hormone Disease
    • 15.3.3. Orphan Disease
    • 15.3.4. Cancer
    • 15.3.5. Cardiovascular Disease
    • 15.3.6. Infectious Disease
    • 15.3.7. Others
  • 15.4. Market Value Forecast By Usage Pattern, 2020-2034
    • 15.4.1. Curative Care
    • 15.4.2. Immunization
    • 15.4.3. Others
  • 15.5. Market Value Forecast By End-user, 2020-2034
    • 15.5.1. Hospitals and Clinics
    • 15.5.2. Ambulatory Surgical Centers
    • 15.5.3. Home Care Settings
    • 15.5.4. Others
  • 15.6. Market Value Forecast By Country, 2020-2034
    • 15.6.1. GCC
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product Type
    • 15.7.2. By Therapeutic Application
    • 15.7.3. By Usage Pattern
    • 15.7.4. By End-user
    • 15.7.5. By Country

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis By Company (2021)
  • 16.3. Market Footprint Analysis
    • 16.3.1. By Region
    • 16.3.2. By Product Type
  • 16.4. Competitive Business Strategies
  • 16.5. Company Profiles
    • 16.5.1. Market Player - Competition Matrix (By Tier and Size of Companies)
    • 16.5.2. Market Share Analysis, by Company (2023)
    • 16.5.3. Company Profiles
      • 16.5.3.1. Becton, Dickinson, and Company (BD)
        • 16.5.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
        • 16.5.3.1.2. Product Portfolio
        • 16.5.3.1.3. Financial Overview
        • 16.5.3.1.4. SWOT Analysis
        • 16.5.3.1.5. Strategic Overview
      • 16.5.3.2. Pfizer, Inc.
        • 16.5.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
        • 16.5.3.2.2. Product Portfolio
        • 16.5.3.2.3. Financial Overview
        • 16.5.3.2.4. SWOT Analysis
        • 16.5.3.2.5. Strategic Overview
      • 16.5.3.3. Eli Lilly and Company
        • 16.5.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
        • 16.5.3.3.2. Product Portfolio
        • 16.5.3.3.3. Financial Overview
        • 16.5.3.3.4. SWOT Analysis
        • 16.5.3.3.5. Strategic Overview
      • 16.5.3.4. Baxter International, Inc.
        • 16.5.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
        • 16.5.3.4.2. Product Portfolio
        • 16.5.3.4.3. Financial Overview
        • 16.5.3.4.4. SWOT Analysis
        • 16.5.3.4.5. Strategic Overview
      • 16.5.3.5. Terumo Corporation
        • 16.5.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
        • 16.5.3.5.2. Product Portfolio
        • 16.5.3.5.3. Financial Overview
        • 16.5.3.5.4. SWOT Analysis
        • 16.5.3.5.5. Strategic Overview
      • 16.5.3.6. B. Braun Melsungen AG
        • 16.5.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
        • 16.5.3.6.2. Product Portfolio
        • 16.5.3.6.3. Financial Overview
        • 16.5.3.6.4. SWOT Analysis
        • 16.5.3.6.5. Strategic Overview
      • 16.5.3.7. Ypsomed AG
        • 16.5.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
        • 16.5.3.7.2. Product Portfolio
        • 16.5.3.7.3. Financial Overview
        • 16.5.3.7.4. SWOT Analysis
        • 16.5.3.7.5. Strategic Overview
      • 16.5.3.8. Gerresheimer AG
        • 16.5.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
        • 16.5.3.8.2. Product Portfolio
        • 16.5.3.8.3. Financial Overview
        • 16.5.3.8.4. SWOT Analysis
        • 16.5.3.8.5. Strategic Overview
      • 16.5.3.9. SCHOTT Pharma
        • 16.5.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
        • 16.5.3.9.2. Product Portfolio
        • 16.5.3.9.3. Financial Overview
        • 16.5.3.9.4. SWOT Analysis
        • 16.5.3.9.5. Strategic Overview
      • 16.5.3.10. Hi-Tech Syringes
        • 16.5.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
        • 16.5.3.10.2. Product Portfolio
        • 16.5.3.10.3. Financial Overview
        • 16.5.3.10.4. SWOT Analysis
        • 16.5.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 02: Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Devices, 2020-2034
  • Table 03: Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Formulations, 2020-2034
  • Table 04: Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Therapeutic Application, 2020-2034
  • Table 05: Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Usage Pattern, 2020-2034
  • Table 06: Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 07: Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Region, 2020-2034
  • Table 08: North America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Country, 2020-2034
  • Table 09: North America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 10: North America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Devices, 2020-2034
  • Table 11: North America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Formulations, 2020-2034
  • Table 12: North America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Therapeutic Application, 2020-2034
  • Table 13: North America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Usage Pattern, 2020-2034
  • Table 14: North America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 15: Europe Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 16: Europe Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 17: Europe Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Devices, 2020-2034
  • Table 18: Europe Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Formulations, 2020-2034
  • Table 19: Europe Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Therapeutic Application, 2020-2034
  • Table 20: Europe Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Usage Pattern, 2020-2034
  • Table 21: Europe Injectable Drug Delivery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 22: Asia Pacific Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 23: Asia Pacific Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 24: Asia Pacific Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Devices, 2020-2034
  • Table 25: Asia Pacific Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Formulations, 2020-2034
  • Table 26: Asia Pacific Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Therapeutic Application, 2020-2034
  • Table 27: Asia Pacific Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Usage Pattern, 2020-2034
  • Table 28: Asia Pacific Injectable Drug Delivery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 29: Latin America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 30: Latin America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 31: Latin America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Devices, 2020-2034
  • Table 32: Latin America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Formulations, 2020-2034
  • Table 33: Latin America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Therapeutic Application, 2020-2034
  • Table 34: Latin America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Usage Pattern, 2020-2034
  • Table 35: Latin America Injectable Drug Delivery Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 36: Middle East & Africa Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 37: Middle East & Africa Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 38: Middle East & Africa Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Devices, 2020-2034
  • Table 39: Middle East & Africa Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Formulations, 2020-2034
  • Table 40: Middle East & Africa Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Therapeutic Application, 2020-2034
  • Table 41: Middle East & Africa Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Usage Pattern, 2020-2034
  • Table 42: Middle East & Africa Injectable Drug Delivery Market Size (US$ Bn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Injectable Drug Delivery Market Value (US$ Bn) Forecast, 2020-2034
  • Figure 02: Global Injectable Drug Delivery Market Value Share, by Product Type, 2023
  • Figure 03: Global Injectable Drug Delivery Market Value Share, by Therapeutic Application, 2023
  • Figure 04: Global Injectable Drug Delivery Market Value Share, by Usage Pattern, 2023
  • Figure 05: Global Injectable Drug Delivery Market Value Share, by End-user, 2023
  • Figure 06: Global Injectable Drug Delivery Market Value Share, by Region, 2023
  • Figure 07: Global Injectable Drug Delivery Market Value (US$ Bn) Share Analysis, by Product Type, 2023 and 2034
  • Figure 08: Global Injectable Drug Delivery Market Share Analysis, by Product Type, 2023
  • Figure 09: Global Injectable Drug Delivery Market Share Analysis, by Product Type, 2034
  • Figure 10: Global Injectable Drug Delivery Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 11: Global Injectable Drug Delivery Market Value (US$ Bn), by Devices Product Type, 2020-2034
  • Figure 12: Global Injectable Drug Delivery Market Value Share Analysis, by Devices Product Type, 2023 and 2034
  • Figure 13: Global Injectable Drug Delivery Market Value (US$ Bn), by Formulations Product Type, 2020-2034
  • Figure 14: Global Injectable Drug Delivery Market Value Share Analysis, by Formulations Product Type, 2023 and 2034
  • Figure 15: Global Injectable Drug Delivery Market Value (US$ Bn) Share Analysis, by Therapeutic Application, 2023 and 2034
  • Figure 16: Global Injectable Drug Delivery Market Share Analysis, by Therapeutic Application, 2023
  • Figure 17: Global Injectable Drug Delivery Market Share Analysis, by Therapeutic Application, 2034
  • Figure 18: Global Injectable Drug Delivery Market Attractiveness Analysis, by Therapeutic Application, 2024-2034
  • Figure 19: Global Injectable Drug Delivery Market Value (US$ Bn), by Autoimmune Disease, 2020-2034
  • Figure 20: Global Injectable Drug Delivery Market Value Share Analysis, by Autoimmune Disease, 2023 and 2034
  • Figure 21: Global Injectable Drug Delivery Market Value (US$ Bn), by Hormone Disease, 2020-2034
  • Figure 22: Global Injectable Drug Delivery Market Value (US$ Bn), by Hormone Disease, 2020-2034
  • Figure 23: Global Injectable Drug Delivery Market Value (US$ Bn), by Orphan Disease, 2020-2034
  • Figure 24: Global Injectable Drug Delivery Market Value Share Analysis, by Orphan Disease, 2023 and 2034
  • Figure 25: Global Injectable Drug Delivery Market Value (US$ Bn), by Cancer, 2020-2034
  • Figure 26: Global Injectable Drug Delivery Market Value Share Analysis, by Cancer, 2023 and 2034
  • Figure 27: Global Injectable Drug Delivery Market Value (US$ Bn), by Cardiovascular Disease, 2020-2034
  • Figure 28: Global Injectable Drug Delivery Market Value Share Analysis, by Cardiovascular Disease, 2023 and 2034
  • Figure 29: Global Injectable Drug Delivery Market Value (US$ Bn) Share Analysis, by Infectious Disease, 2023 and 2034
  • Figure 30: Global Injectable Drug Delivery Market Value Share Analysis, by Infectious Disease, 2023 and 2034
  • Figure 31: Global Injectable Drug Delivery Market Value (US$ Bn) Share Analysis, by Others, 2023 and 2034
  • Figure 32: Global Injectable Drug Delivery Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 33: Global Injectable Drug Delivery Market Value (US$ Bn) Share Analysis, by Usage Pattern, 2023 and 2034
  • Figure 34: Global Injectable Drug Delivery Market Share Analysis, by Usage Pattern, 2023
  • Figure 35: Global Injectable Drug Delivery Market Share Analysis, by Usage Pattern, 2034
  • Figure 36: Global Injectable Drug Delivery Market Attractiveness Analysis, by Usage Pattern, 2024-2034
  • Figure 37: Global Injectable Drug Delivery Market Value (US$ Bn), by Curative Care, 2020-2034
  • Figure 38: Global Injectable Drug Delivery Market Value Share Analysis, by Curative Care, 2023 and 2034
  • Figure 39: Global Injectable Drug Delivery Market Value (US$ Bn), by Immunization, 2020-2034
  • Figure 40: Global Injectable Drug Delivery Market Value Share Analysis, by Immunization, 2023 and 2034
  • Figure 41: Global Injectable Drug Delivery Market Value (US$ Bn), by Others, 2020-2034
  • Figure 42: Global Injectable Drug Delivery Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 43: Global Injectable Drug Delivery Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 44: Global Injectable Drug Delivery Market Share Analysis, by End-user, 2023
  • Figure 45: Global Injectable Drug Delivery Market Share Analysis, by End-user, 2034
  • Figure 46: Global Injectable Drug Delivery Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 47: Global Injectable Drug Delivery Market Value (US$ Bn), by Hospitals and Clinics, 2020-2034
  • Figure 48: Global Injectable Drug Delivery Market Value Share Analysis, by Hospitals and Clinics, 2023 and 2034
  • Figure 49: Global Injectable Drug Delivery Market Value (US$ Bn), by Ambulatory Surgical Centers, 2020-2034
  • Figure 50: Global Injectable Drug Delivery Market Value Share Analysis, by Ambulatory Surgical Centers, 2023 and 2034
  • Figure 51: Global Injectable Drug Delivery Market Value (US$ Bn), by Home Care Settings, 2020-2034
  • Figure 52: Global Injectable Drug Delivery Market Value Share Analysis, by Home Care Settings, 2023 and 2034
  • Figure 53: Global Injectable Drug Delivery Market Value (US$ Bn), by Others, 2020-2034
  • Figure 54: Global Injectable Drug Delivery Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 55: Global Injectable Drug Delivery Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 56: Global Injectable Drug Delivery Market Share Analysis, by Region, 2023
  • Figure 57: Global Injectable Drug Delivery Market Share Analysis, by Region, 2034
  • Figure 58: Global Injectable Drug Delivery Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 59: North America Injectable Drug Delivery Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 60: North America Injectable Drug Delivery Market Attractiveness Analysis, by Country, 2024-2034